Phase I trial of a twice-daily regimen of amifostine with ifosfamide, carboplatin, and etoposide chemotherapy in children with refractory carcinoma
Maryam Fouladi, Diana Stempak, Janet Gammon, Julia Klein, Ron Grant, Mark L. Greenberg, Gideon Koren, Sylvain Baruchel
Research output: Contribution to journal › Article › peer-review
23Scopus
citations
Fingerprint
Dive into the research topics of 'Phase I trial of a twice-daily regimen of amifostine with ifosfamide, carboplatin, and etoposide chemotherapy in children with refractory carcinoma'. Together they form a unique fingerprint.